PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPURE.L Regulatory News (PURE)

  • There is currently no data for PURE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

27 Sep 2011 09:26

RNS Number : 9903O
PureCircle Limited
27 September 2011
 



PURECIRCLE LIMITED

 

("PureCircle" or "the Company")

 

 

DEALING IN SHARES

 

PureCircle (LSE: PURE), the world's leading supplier and marketer of high purity stevia products has been notified of the following purchase of shares by a Director on 26th September 2011:

 

Director Number of shares purchased Price per share

Mr Lai Hock Meng 10,000 £0.85

 

 

27 September 2011

 

 

For more information:

PureCircle Limited (www.purecircle.com)

Magomet Malsagov, CEO

+60 1 2388 8049

William Mitchell, CFO

+44 7974 005 163

RFC Corporate Finance Ltd (NOMAD)

+61 8 9480 2500

Steve Allen

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLIFFTAFIDFIL
Date   Source Headline
14th Mar 20117:00 amRNSInterim Results and Investor Conference Call
13th Jan 20117:00 amRNSTrading Statement
15th Dec 201012:00 pmRNSAGM Statement
23rd Nov 20107:00 amRNSAGM Statement
9th Nov 20107:00 amRNSLong term incentive plan: Issue of shares
29th Oct 20107:00 amRNSDirector/PDMR Shareholding
28th Oct 20107:00 amRNSRe Audited accounts
23rd Sep 20108:08 amRNSRe Joint Venture
23rd Sep 20107:43 amRNSRe Joint Venture
22nd Sep 20107:00 amRNSRe Joint Venture
22nd Sep 20107:00 amRNSFull Year Results
31st Aug 20107:00 amRNSNotice of Allowance for patent
3rd Aug 20107:00 amRNSStevia Trust Mark marketing campaign
29th Jul 20107:00 amRNSRe Global Quality Leaf Sourcing Strategy
28th Jul 20107:00 amRNSMajor contract wins
27th Jul 20107:00 amRNSInterim Management Statement
27th Jul 20107:00 amRNSProposed Joint Venture
26th Jul 20107:00 amRNSGlobal Sales and Marketing VP appointed
21st Jul 20107:00 amRNSFDA 'No Objection' ruling on new product
25th Jun 201012:02 pmRNSGlobal Stevia Institute announces key members
26th May 20107:00 amRNSLaunch of Global Stevia Institute
5th May 20107:00 amRNSNew products launching at a greater rate
14th Apr 20106:25 pmRNSEFSA evaluates the safety of steviol glycosides
6th Apr 20107:00 amRNSUpdate on New Product Launches
1st Apr 20109:59 amRNSChange of significant Shareholding
30th Mar 201011:18 amRNSIssue of new shares and exercise of options
22nd Mar 20107:00 amRNSHalf Yearly Report
5th Mar 20107:00 amRNSNotice of Results
4th Mar 20107:00 amRNSProduct Launches
26th Feb 20107:00 amRNSManagement changes
22nd Feb 20107:00 amRNSRe Joint Venture
9th Feb 20109:27 amRNSChange of Significant Shareholding
1st Feb 20107:00 amRNSAppointment of Joint Corporate Broker
29th Jan 20107:00 amRNSProduct Launch
14th Jan 20109:09 amRNSRe Agreement
18th Dec 20097:00 amRNSSignificant shareholding
17th Dec 20097:00 amRNSSignificant Shareholders and Notifiable Interest
8th Dec 20099:11 amRNSissue of shares
24th Nov 200910:17 amRNSResult of AGM
23rd Nov 20097:00 amRNSNotifiable Interests
19th Nov 20097:00 amRNSissue of shares
18th Nov 20097:00 amRNSPlacing
16th Nov 20097:00 amRNSPureCircle collaboration with Nestle Malaysia
13th Nov 20097:00 amRNSPureCircle wins major award
11th Nov 20097:00 amRNSExpansion of supply source
6th Nov 20097:00 amRNSProduct Launch
4th Nov 20097:00 amRNSStevia product launches hit 200
2nd Nov 200911:15 amRNSAnnual Financial Report
30th Oct 20097:00 amRNSNotice of AGM
30th Oct 20097:00 amRNSStatement re Collaboration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.